119 related articles for article (PubMed ID: 27860223)
1. Validation of risk stratification for children with febrile neutropenia in a pediatric oncology unit in India.
Das A; Trehan A; Oberoi S; Bansal D
Pediatr Blood Cancer; 2017 Jun; 64(6):. PubMed ID: 27860223
[TBL] [Abstract][Full Text] [Related]
2. Predictive value of PCT and IL-6 for bacterial infection in children with cancer and febrile neutropenia.
van der Galiën HT; Loeffen EAH; Miedema KGE; Tissing WJE
Support Care Cancer; 2018 Nov; 26(11):3819-3826. PubMed ID: 29777383
[TBL] [Abstract][Full Text] [Related]
3. Risk predictors for adverse outcome in pediatric febrile neutropenia: Single center experience from a low and middle-income country.
Prasad M; Chinnaswamy G; Arora B; Vora T; Hawaldar R; Banavali S
Indian J Cancer; 2014; 51(4):432-7. PubMed ID: 26842150
[TBL] [Abstract][Full Text] [Related]
4. Predicting adverse events in children with fever and chemotherapy-induced neutropenia: the prospective multicenter SPOG 2003 FN study.
Ammann RA; Bodmer N; Hirt A; Niggli FK; Nadal D; Simon A; Ozsahin H; Kontny U; Kühne T; Popovic MB; Lüthy AR; Aebi C
J Clin Oncol; 2010 Apr; 28(12):2008-14. PubMed ID: 20231680
[TBL] [Abstract][Full Text] [Related]
5. Multisite external validation of a risk prediction model for the diagnosis of blood stream infections in febrile pediatric oncology patients without severe neutropenia.
Esbenshade AJ; Zhao Z; Aftandilian C; Saab R; Wattier RL; Beauchemin M; Miller TP; Wilkes JJ; Kelly MJ; Fernbach A; Jeng M; Schwartz CL; Dvorak CC; Shyr Y; Moons KGM; Sulis ML; Friedman DL
Cancer; 2017 Oct; 123(19):3781-3790. PubMed ID: 28542918
[TBL] [Abstract][Full Text] [Related]
6. Risk factors associated with complications in patients with chemotherapy-induced febrile neutropenia in emergency department.
Lynn JJ; Chen KF; Weng YM; Chiu TF
Hematol Oncol; 2013 Dec; 31(4):189-96. PubMed ID: 23303687
[TBL] [Abstract][Full Text] [Related]
7. Can complications in febrile neutropenia be predicted? Report from a developing country.
Oberoi S; Das A; Trehan A; Ray P; Bansal D
Support Care Cancer; 2017 Nov; 25(11):3523-3528. PubMed ID: 28601903
[TBL] [Abstract][Full Text] [Related]
8. Development of a simplified multivariable model to predict neutropenic complications in cancer patients undergoing chemotherapy.
Razzaghdoust A; Mofid B; Moghadam M
Support Care Cancer; 2018 Nov; 26(11):3691-3699. PubMed ID: 29736867
[TBL] [Abstract][Full Text] [Related]
9. Predicting bacteremia in children with cancer and fever in chemotherapy-induced neutropenia: results of the prospective multicenter SPOG 2003 FN study.
Agyeman P; Aebi C; Hirt A; Niggli FK; Nadal D; Simon A; Ozsahin H; Kontny U; Kühne T; Beck Popovic M; Leibundgut K; Bodmer N; Ammann RA
Pediatr Infect Dis J; 2011 Jul; 30(7):e114-9. PubMed ID: 21394050
[TBL] [Abstract][Full Text] [Related]
10. Management of febrile neutropenia in malignancy using the MASCC score and other factors: Feasibility and safety in routine clinical practice.
Kumar P; Bajpai J; Shetty N; Medekar A; Kurkure PA; Ghadyalpatil N; Gupta S; Noronha V; Kanujia A; Parikh P; Banavali SD
Indian J Cancer; 2014; 51(4):491-5. PubMed ID: 26842174
[TBL] [Abstract][Full Text] [Related]
11. Prospective validation of a risk prediction model for severe sepsis in children with cancer and high-risk febrile neutropenia.
Santolaya ME; Alvarez AM; Avilés CL; Becker A; Venegas M; O'Ryan M; Salgado C; Topelberg S; Tordecilla J; Varas M; Villarroel M; Viviani T; Zubieta M; de la Maza V; Vergara A; Farfán MJ; Torres JP
Pediatr Infect Dis J; 2013 Dec; 32(12):1318-23. PubMed ID: 24569305
[TBL] [Abstract][Full Text] [Related]
12. Identification of children presenting with fever in chemotherapy-induced neutropenia at low risk for severe bacterial infection.
Ammann RA; Hirt A; Lüthy AR; Aebi C
Med Pediatr Oncol; 2003 Nov; 41(5):436-43. PubMed ID: 14515382
[TBL] [Abstract][Full Text] [Related]
13. Factors predicting outcome in high risk febrile neutropenia in patients receiving intensive chemotherapy for acute sleukemia: A prospective, observational study from South India.
Rajendranath R; Balasubramaniyum VK; Vijayakumar V; Ganesan P; Tenali GS
Indian J Cancer; 2014; 51(4):481-6. PubMed ID: 26842171
[TBL] [Abstract][Full Text] [Related]
14. Decision-tree derivation and external validation of a new clinical decision rule (DISCERN-FN) to predict the risk of severe infection during febrile neutropenia in children treated for cancer.
Delebarre M; Gonzales F; Behal H; Tiphaine A; Sudour-Bonnange H; Lutun A; Abbou S; Pertuisel S; Thouvenin-Doulet S; Pellier I; Mansuy L; Piguet C; Paillard C; Blanc L; Thebaud E; Plantaz D; Blouin P; Schneider P; Guillaumat C; Simon P; Domenech C; Pacquement H; Le Meignen M; Pluchart C; Vérite C; Plat G; Martinot A; Duhamel A; Dubos F
Lancet Child Adolesc Health; 2022 Apr; 6(4):260-268. PubMed ID: 34871572
[TBL] [Abstract][Full Text] [Related]
15. Safety of discharge for children with cancer and febrile neutropenia off antibiotics using absolute neutrophil count threshold values as a surrogate marker for adequate bone marrow recovery.
Campbell ME; Friedman DL; Dulek DE; Zhao Z; Huang Y; Esbenshade AJ
Pediatr Blood Cancer; 2018 Mar; 65(3):. PubMed ID: 29115709
[TBL] [Abstract][Full Text] [Related]
16. Predicting bacterial infections among pediatric cancer patients with febrile neutropenia: External validation of the PICNICC model.
Ojha RP; Asdahl PH; Steyerberg EW; Schroeder H
Pediatr Blood Cancer; 2018 Apr; 65(4):. PubMed ID: 29286572
[TBL] [Abstract][Full Text] [Related]
17. Pattern of infection, therapy, outcome and risk stratification of patients with febrile neutropenia in a tertiary care oncology hospital in India.
Noronha V; Joshi A; Patil VM; Bhosale B; Muddu VK; Banavali S; Kelkar R; Prabhash K
Indian J Cancer; 2014; 51(4):470-4. PubMed ID: 26842166
[TBL] [Abstract][Full Text] [Related]
18. Prediction of serious complications in patients with seemingly stable febrile neutropenia: validation of the Clinical Index of Stable Febrile Neutropenia in a prospective cohort of patients from the FINITE study.
Carmona-Bayonas A; Jiménez-Fonseca P; Virizuela Echaburu J; Antonio M; Font C; Biosca M; Ramchandani A; Martínez J; Hernando Cubero J; Espinosa J; Martínez de Castro E; Ghanem I; Beato C; Blasco A; Garrido M; Bonilla Y; Mondéjar R; Arcusa Lanza MÁ; Aragón Manrique I; Manzano A; Sevillano E; Castañón E; Cardona M; Gallardo Martín E; Pérez Armillas Q; Sánchez Lasheras F; Ayala de la Peña F
J Clin Oncol; 2015 Feb; 33(5):465-71. PubMed ID: 25559804
[TBL] [Abstract][Full Text] [Related]
19. Predicting fever in neutropenia with safety-relevant events in children undergoing chemotherapy for cancer: The prospective multicenter SPOG 2015 FN Definition Study.
Lavieri L; Koenig C; Bodmer N; Agyeman PKA; Scheinemann K; Ansari M; Roessler J; Ammann RA
Pediatr Blood Cancer; 2021 Dec; 68(12):e29253. PubMed ID: 34310027
[TBL] [Abstract][Full Text] [Related]
20. The diagnostic value of C-reactive protein, interleukin-8, and monocyte chemotactic protein in risk stratification of febrile neutropenic children with hematologic malignancies.
El-Maghraby SM; Moneer MM; Ismail MM; Shalaby LM; El-Mahallawy HA
J Pediatr Hematol Oncol; 2007 Mar; 29(3):131-6. PubMed ID: 17356388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]